Olfactory Pathways as a Research Target — Exploring Nose-to-Brain Transport Mechanisms

Olfactory Pathways as a Research Target — Exploring Nose-to-Brain Transport Mechanisms

The nasal cavity is more than a respiratory gateway — it is one of the most strategically important and biologically unique regions of interest in modern delivery-science research. Among its features, the olfactory pathway stands out as a direct anatomical bridge between the external environment and neural structures. This connection has captured the attention of neuroscientists, peptide researchers, and formulation scientists worldwide.

At AERIS BIOSCIENCES™, we focus on producing research-grade compounds that allow laboratories to study these pathways with precision, clarity, and reproducibility.

Why the Olfactory Pathway Matters in Research

Unlike traditional delivery routes, olfactory tissues sit only a few cell layers away from brain-adjacent structures, offering a rare interface for studying:

  • Direct neuro-access potential

  • Axonal transport mechanisms

  • Rapid signaling pathways

  • Mucosal–neuronal interactions

  • Non-invasive brain-delivery models

A foundational review notes that the nasal cavity “offers direct access to the central nervous system through the olfactory and trigeminal neural pathways,” creating opportunities for studying nose-to-brain transport in experimental settings.
(Cells – MDPI)

How Nose-to-Brain Transport is Thought to Occur (in Preclinical Models)

Laboratory research identifies two primary routes:

1. The Olfactory Nerve Route

Compounds deposited in the upper nasal cavity may interact with:

  • Olfactory receptor neurons

  • Supporting epithelial cells

  • Cribriform plate channels

These structures create a direct neuronal path toward the olfactory bulb.
A 2023 review highlights that olfactory nerves provide “a unique conduit to deliver molecules to the CNS” in research environments.
(MDPI – Pharmaceutics)

2. The Trigeminal Nerve Route

The trigeminal system innervates the respiratory region and also connects to deeper neural structures.
Several studies point to this pathway as a secondary but significant mechanism for nasal-to-brain transport, especially for peptides and small molecules.
(Frontiers in Pharmacology)

Together, these pathways create a dual-channel research model for studying central nervous system access from nasal administration.

Advantages of Olfactory-Based Research Models

Research into olfactory transport offers unique benefits:

A. Direct Access for Study

The nasal cavity provides a rare opportunity to bypass gastrointestinal and hepatic processing in experimental models — enabling more controlled investigation into CNS-relevant compounds.

B. Rapid Onset in Neural Tissues (Preclinical Studies)

Preclinical papers consistently note faster detection of compounds in the olfactory bulb and related structures following intranasal delivery in animal models.

C. Non-Invasive Administration Models

Olfactory studies reduce the need for surgical or invasive experimental procedures in certain preclinical workflows.

D. Ideal for Studying Peptides & Biologics

Many peptides struggle with oral bioavailability and enzymatic degradation; the olfactory pathway allows researchers to study their behavior in a different context.

Molecular Characteristics That Favor Nose-to-Brain Transport (Research-Supported)

Certain features appear consistently in successful preclinical findings:

  • Low molecular weight

  • High lipophilicity or optimized hydrophilicity

  • Peptides stable against mucosal enzymes

  • Nanocarriers or permeation enhancers

  • Formulations designed for targeted nasal deposition

One review notes that “carrier systems such as liposomes, nanoparticles and cell-penetrating peptides significantly enhance transport efficiency in nose-to-brain studies.”
(Cells – MDPI)

The Role of Formulation Science

AERIS BIOSCIENCES™ engineers research-grade nasal formulations to support studies involving:

  • Compound stability in the olfactory region

  • Diffusion and mucosal interaction

  • Permeation enhancer effectiveness

  • Droplet size and deposition patterns

  • Carrier-assisted delivery strategies

Our goal is not to direct outcomes, but to equip researchers with materials that provide dependable, high-fidelity data.

Current Research Themes in Olfactory Delivery

Across laboratories and academic centers, common investigatory threads include:

  • Neurotrophic peptide transport

  • Mitochondrial and metabolic peptides in CNS models

  • Inflammation-modulating compounds

  • Nanoparticle-assisted delivery systems

  • Degenerative disease model research

  • Axonal transport dynamics

  • Rapid-onset pharmacokinetics in CNS tissues

A significant body of evidence supports the continued exploration of this pathway in laboratory settings.

AERIS BIOSCIENCES™: Advancing the Research Frontier

Our nasal-format compounds are:

  • COA-verified

  • Stability-assessed

  • Produced in ISO-aligned environments

  • Designed for reproducibility

  • Intended strictly for laboratory use

By prioritizing purity, consistency and precision, we empower researchers to investigate olfactory pathways with full confidence in the materials they use.

Conclusion

The olfactory pathway represents one of the most compelling frontiers in modern delivery science. From direct neural access to rapid CNS-distribution models, its mechanisms continue to inspire groundbreaking research across neuroscience, peptide biology and formulation science.

AERIS BIOSCIENCES™ stands committed to supporting this work — where air meets molecule, and discovery meets possibility.

Research-Use-Only Notice

All compounds referenced and all AERIS products are intended solely for laboratory research. They are not approved for human or veterinary use, consumption or therapeutic application.

Key References for Further Reading:

  • De Martini L.B. et al., Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery… (2023) — MDPI Cells.

  • Alabsi W. et al., Nose-to-Brain Delivery of Therapeutic Peptides as Nasal … (2022) — MDPI Pharmaceutics.

  • Maeng J. et al., Systemic and brain delivery of antidiabetic peptides by nasal route… (2022) — Frontiers in Pharmacology.

Previous
Previous

Semax & Selank — Nasal-Format Research Compounds and Emerging Preclinical Insights